ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease.
Where this comes from
- Record sourced from PubMed, PMID 32238379.
- Also identified by DOI 10.3949/ccjm.87a.19078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2018 and 2019 guidelines from the American College of Cardiology and American Heart Association reflect the complexity of individualized cholesterol management. The documents address more detailed risk assessment, newer nonstatin cholesterol-lowering drugs, special attention to patient subgroups, and consideration of the value of therapy, all with the aim of creating personalized treatment plans for each patient. Overall, the guidelines recommend shared decision-making to meet the individual needs of each patient.
Medical subject headings
- Cardiovascular Diseases